Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 263-271

  Rus, H G ^a,b   Vlaicu, R ^a   Niculescu, F ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

atherogenesis; C5b 9; complement activation; IL 6; IL 8

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CONNECTIVE TISSUE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

AORTA; ARTERIOSCLEROSIS; CELLS, CULTURED; DNA; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES; RNA;

EID: 0030596136     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05968-0     Document Type: Article

References (39)

1. [1] Stemme S, Hansson GK. Immune mechanisms in atherogenesis. Ann Med 1994;26:141-146.
2. [2] Tedgui A, Bernard C. Cytokine, immuno-inflammatory response and atherosclerosis. Eur Cytokine Net 1994;5:263-270.
3. [3] Vlaicu R, Rus HG, Niculescu F, Cristea A. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 1985;55:35-50.
4. [4] Niculescu F, Rus HG, Vlaicu R. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis. Atherosclerosis 1987;65:1-11.
5. [5] Stemme S, Rymo L, Hansson GK, Polyclonal origin of T lymphocytes in human atherosclerotic plaque. Lab Invest 1991;65:654-660.
6. [6] Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;116:1292-1300.
7. [7] Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991;89:247-254.
8. [8] Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester FJ. Tumor necrosis factor gene in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol 1990;137:503-509.
9. [9] Nelken NA, Coughlin SR, Gordon D, Wilcox, JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;8:1121-1127.
10. [10] Yla-Herttula S, Lipton BA, Rosenfeld ME et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-5256.
11. [11] Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717-9721.
12. [12] Ikeda U, Ikeda M, Seino Y, Takahashi M, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis 1992;92:213-218.
13. [13] Salmono RN, Underwood R, Doyle MV, Wang A, Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci USA 1992;89:2814-2818.
14. [14] Seino Y, Ikeda U, Ikeda M et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
15. [15] Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993:54:1-78.
16. [16] Aarden L, Helle M, Boeije L, Pascual-Salcedo D, de Groot E. Differential induction of interleukin-6 production in monocytes, endothelial cells and smooth muscle cells. Eur Cytokine Net 1991;2:115-120.
17. [17] Gimbrone M. Jr, Obin MS, Brock AF et al. Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions. Science 1989;246:1601-1603.
18. [18] Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1993;55:97-179.
19. [19] Wang JM, Sica A, Peri G et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1166-1174.
20. [20] Brown Z, Gerritsen ME, Carley WW, Stricter RM, Kunkel SL, Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Am J Pathol 1994;145:913-921.
21. [21] Ikeda U, Ikeda M, Oohara T et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 1991;260:H713-H717.
22. [22] Morimoto S, Nabata T, Koh E et al. Interleukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1β. J Cardiovasc Pharmacol 1991;17:S117-S118.
23. [23] Yue TL, Wang X, Sung CP et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994;75;1-17.
24. [24] Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994;14:47-53.
25. [25] Rus HG, Niculescu F, Porutiu D, Ghiurca V, Vlaicu R. Cells carrying C5b-9 complement complexes in human atherosclerotic wall. Immunol Lett 1989;20:305-310.
26. [26] Niculescu F, Hugo F, Rus HG, Vlaicu R, Bhakdi S. Quantitative evaluation of terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries. Clin Exp Immunol 1987;69:477-483.
27. [27] Niculescu F, Rus HG, Vlaicu R. Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall. Immunol Lett, 1990;26:17-24.
28. [28] Niculescu F, Rus H, Shin ML. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J Biol Chem 1994;269:4417-4423.
29. [29] Niculescu F, Rus H, Shin S, Lang T, Shin ML. Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol 1993;150:214-224.
30. [30] Rus HG, Kim LM, Niculescu F, Shin ML. Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J Immunol 1992;148:928-933.
31. [31] Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, pp. 14.5-14.20.
32. [32] Halperin JA, Taratuska A, Nicholsson-Weller A. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells, J Clin Invest 1993;91:1974-1978.
33. [33] Evans SW, Farrar WL. Interleukin 2 and diacylglycerol stimulate phosphorylation of 40S ribosomal S6 protein. Correlation with increased protein synthesis and S6 kinase activation, J Biol Chem 1987;262:4624-4630.
34. [34] Edelmann HML, Kuhne C, Petritsch C, Ballou LM. Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts, J Biol Chem 1996;271:963-971.
35. [35] Remick DG, DeForge LE, Sullivan JF, Showell HJ. Profile of cytokines in synovial fluid specimens from patients with arthritis. IL-8 and IL-6 correlate with inflammatory arthritides. Immunol Invest 1992;21:321-327.
36. [36] Symons JA, Wong WL, Palladino MA, Duff GW, Interleukin 8 in rheumatoid and ostheoarthritis. Scand J Immunol 1992;21:92-94.
37. [37] Schalz W, McClug MR, Cardenas GJ et al. C5a mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 1990;57:297-307.
38. [38] Ember JA, Sanderson SD, Hugli TE, Morgan EL. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 1994;144:393-403.
39. [39] Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1994;258:1798-1801.